Holon

Sophont has introduced Holon-S1, a system that maps a tumour's biology from a single biopsy sample. The technology aims to give clinicians a fuller picture of a cancer's characteristics without requiring multiple tissue samples, potentially aiding diagnosis and treatment planning. Coverage so far is limited, and details on validation, regulatory status or clinical adoption have not yet been made widely available.